Dr. Kamp is a faculty member in the Division of Cardiovascular Medicine within the Department of Medicine. He holds the Stem Cell and Regenerative Medicine Research Professorship and is director of the University of Wisconsin Stem Cell and Regenerative Medicine Center.
Dr. Kamp's teaching activities focus on cardiac electrophysiology and cardioregenerative medicine. In 2012, he received the Cozzarelli Prize for an outstanding article in Proceedings of National Academies of Sciences that recognizes outstanding contributions to the scientific disciplines represented by the National Academy of Sciences. In 2017, Dr. Kamp received the Rankin Research Award, given to a senior member of the Department of Medicine faculty who has made a significant research contribution toward advancing the field of medicine. He is a member of numerous academic societies, including the American College of Cardiology, the American Heart Association Council on Basic Cardiovascular Sciences, the International Society for Stem Cell Research and the International Society for Heart Research. He is a fellow of the American College of Cardiology and the American Heart Association.
Dr. Kamp participates widely in peer-review activities, including being on the editorial board for the Journal of Molecular and Cellular Cardiology and a regular reviewer for multiple cardiovascular-related journals. He has served on multiple peer review panels, including for the American Heart Association and National Institutes of Health.
Dr. Kamp's clinical activities include general consultative cardiology and cardiac care for patients with neuromuscular disorders and muscular dystrophies.
View Dr. Kamp's publications on NCBI MyBibliography.
Dr. Kamp’s research investigates the underlying molecular and cellular abnormalities that cause arrhythmias and heart failure with the goal of innovating new therapies. Human pluripotent stem cells are an important tool in this research enabling studies of patient-specific genetic causes of arrhythmias and heart failure. Cardiac regenerative medicine approaches are being actively pursued to repaired injured heart muscle seeking optimal cell preparations derived from human induced pluripotent stem cells.